Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

28.58 -0.22 (-0.76%)
Official Closing Price Updated: 7:00 PM EDT, Jun 7, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 27,526,237
Open 28.75
Bid (Size) 28.56 (22)
Ask (Size) 28.57 (3)
Prev. Close 28.80
Today's Range 28.55 - 29.05
52wk Range 25.20 - 40.37
Shares Outstanding 5,606,688,356
Dividend Yield 5.74%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Masters In Trading - Saturday, June 8
In this video, I review the most recent trading session. I also discuss what a trader's 
Via Talk Markets
3 Stocks With Mouthwatering Dividends You Can Buy Right Now
These stocks offer great dividends and more. 
Via The Motley Fool

Performance

YTD
-3.87%
-3.87%
1 Month
+1.42%
+1.42%
3 Month
+0.74%
+0.74%
6 Month
-0.21%
-0.21%
1 Year
-26.66%
-26.66%

More News

Read More
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
Via Benzinga
Exposures COVID-19 Product Safety
2 Dividend Stocks Billionaires Are Buying: Should You?
Via The Motley Fool
Meme Stocks Surge Led by ‘Roaring Kitty’ and Social Media Buzz on Reddit (NYSE: RDDT), GME, DYAI, AMC, PRSO, NVAX
Via AB Newswire
Check Out What Whales Are Doing With PFE
Via Benzinga
Pfizer Unusual Options Activity For June 03
Via Benzinga
Novavax Stock’s Recent Surge and Future Potential
Via MarketBeat
Topics Economy
Exposures COVID-19 Product Safety Supply Chain
Is a Giant Short Squeeze Brewing in Novavax (NVAX) Stock?
Via InvestorPlace
Exposures COVID-19
Novavax, With A 369% Gain, Tears Ahead Again On Key FDA Move
Via Investor's Business Daily
Exposures COVID-19 Product Safety
Dyadic International Inc. (NASDAQ: DYAI) Hits New 52-Week High Amidst Golden Cross, Bullish Swing Patterns and Bird Flu Concerns
Via AB Newswire
Why Is Novavax (NVAX) Stock Up 20% Today?
Via InvestorPlace
Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with RLY-2608
From Relay Therapeutics, Inc.
Via GlobeNewswire
What's Going On With Novavax Stock?
Via Benzinga
2 High-Yield Dividend Stocks to Buy Right Now
Via The Motley Fool
Alphabet, Ventas, ASML And A Pharmaceutical Giant On CNBC's 'Final Trades'
Via Benzinga
Why Things Could Get Worse for Pfizer Stock Before They Get Better
Via The Motley Fool
7 Dividend Stocks to Invest In for a Lifetime of Income
Via InvestorPlace
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Via Benzinga
The Income Investor’s Dream Team: 7 Sturdy Dividend Stocks Yielding 6%
Via InvestorPlace
7 High-Yield Dividend Stocks That Work While You Sleep
Via InvestorPlace
1 Beaten-Down S&P 500 Dividend Stock to Buy in June and Hold For a Decade or Longer
Via The Motley Fool
Topics Stocks
Exposures US Equities
Large Cap BIopharmaceuticals Overview
Via Talk Markets
Topics Stocks
Exposures US Equities
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
From Pfizer Inc.
Via Business Wire
Hims & Hers Health Soars on Generic GLP-1 Rollout Plans
Via MarketBeat
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.